ZYMERA, INC.

Address

5941 Optical Court
San Jose, CA, 95138-1400

Information

DUNS: 171080885
# of Employees: 5

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of a Protease Activity Assay for Melanoma Prognostics

    Amount: $219,564.00

    DESCRIPTION (provided by applicant): The objective of this Phase I project is the development of novel assays for gelatinase - i.e., matrix metalloprotease 2 and 9 - activity using a proprietary enhan ...

    SBIRPhase I2014Department of Health and Human Services
  2. IGF::OT::IGF OTHER FUNCTIONS RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH) SBIR PHASE II TOPIC NO. 266 PROJECT ENTITLED: HOMOGENEOUS NANO PARTICLE- BASED ASSAYS FOR PROTEASE DETECTION

    Amount: $1,103,426.00

    The objectives of the Phase II project are to further develop a new protease detection technology platform with versatile application capabilities (in vitro and in vivo) including cancer applications ...

    SBIRPhase II2012Department of Health and Human Services
  3. SBIR Phase II: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging

    Amount: $600,296.00

    This Small Business Innovation Research (SBIR) Phase II project will demonstrate the production of robust, versatile probes based on Bioluminescence Resonance Energy Transfer to Quantum Dots (BRET-Qdo ...

    SBIRPhase II2010National Science Foundation
  4. STTR Phase I: Non-Toxic Nanoparticles for BRET-Based Molecular Imaging

    Amount: $150,000.00

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer (STTR) Phase I project will result in the demonstration of no ...

    STTRPhase I2009National Science Foundation
  5. SBIR Phase I: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I project will demonstrate the detection of an established target in cancer diagnosis and treatment using new targeted Bioluminescence Resonance En ...

    SBIRPhase I2009National Science Foundation
  6. SBIR Phase I: Bioluminescence Resonance Energy Transfer Assays for Clinical Chemistry

    Amount: $99,993.00

    This Small Business Innovation Research (SBIR) Phase I research project aims to develop a point-of-care assay for creatine kinase, an important toxicity biomarker, to screen for adverse drug reactions ...

    SBIRPhase I2007National Science Foundation
  7. SBIR TOPIC 266: HOMOGENOUS NANOPARTICLE-BASED ASSAYS FOR PROTEASE DETECTION

    Amount: $199,948.00

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government